BSE filing, NSE: ANG. Summary written from the filing by ALFA Finder's alert engine.
ANG Lifesciences India Ltd: key numbers
- Share price
- ₹33.50
- Market cap
- ₹43.75 Cr
- Revenue (annual)
- ₹92.89 Cr
- Net profit (annual)
- ₹-11.08 Cr
- P/E (TTM)
- -3.3×Sector 46.1×
- Promoter holding
- 70.60%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ANG Lifesciences India Ltd
All →ANG Lifesciences India Other Announcement
The company filed its quarterly shareholding pattern for the period ending September 30, 2026, as per SEBI regulations.
ANG Lifesciences India Management Change
ANG Lifesciences India Ltd announced the re-appointment of Mrs. Chetna as an Independent Director for a second five-year term, effective October 12, 2026.
ANG Lifesciences India Annual General Meeting
ANG Lifesciences India Limited held its 20th Annual General Meeting on September 30, 2026. The meeting successfully transacted routine business items.
ANG Lifesciences India Annual Report
ANG Lifesciences India Limited has submitted its Annual Report for the financial year 2025-26, including the notice convening its 20th Annual General Meeting.
ANG Lifesciences India Annual General Meeting
ANG Lifesciences India Limited has scheduled its 20th Annual General Meeting for September 30, 2026, to be conducted via Video Conference.
ANG Lifesciences India Board Meeting Outcome
ANG Lifesciences announced the outcome of its board meeting, approving the Board's report, appointing a cost auditor, and scheduling the 20th AGM for September 30, 2026.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.